Newmark: 2021 Year-End Life Sciences Overview and Market Clusters







2021 Year-End Life Sciences Overview and Market Clusters

Life sciences remained one of the best performing niche sectors in real estate as tenant and investor demand for lab, incubator and biomanufacturing (BPF) space accelerated while throughout the COVID-19 pandemic.

Contact us

Leave this field blank

Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, St. Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Territory Indian Ocean British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Republic Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grena of Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Islands Northern Marianas Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Republic of the Congo Reunion Romania Russia Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the Sandwich Islands South South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu United States Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe

E-mail address is required

I would like to receive the latest updates from Newmark

By submitting your data via this form, you confirm that you are over 18 years old, that you have read and understood the privacy policy and that you agree to the collection, use and processing of your personal information by Newmark & ​​​​Company Real Estate. , Inc. in accordance with said policy.*

Thank you for sharing your information with Newmark!

Key points to remember

  • Life sciences real estate capital markets activity set an all-time high in 2021, with investment volume reaching $18.4 billion, reflecting immense investor demand and continued liquidity in property markets. clusters.

  • The ten largest life sciences M&A deals in 2021 were worth more than $130 billion, driven by the continued growth of the world’s largest pharmaceutical and biotech companies, such as Merck, Illumina and Thermo Fisher Scientific.

  • The venture capital industry’s pivot to life sciences propelled funding to an all-time high of $43.3 billion in 2021, representing a compound annual growth rate of 21.3% over the of the last 10 years.

  • For Class A products in the major urban life sciences markets of Cambridge, South San Francisco, Sorrento Mesa and South Lake Union, prices have reached over 1,000 PSF in 2021, with higher prices over close to $2,000 PSF for best-in-class trumps.

Download 2021 Year-End Life Sciences Overview and Market Cluster Report Download 2021 Year-End Life Sciences Overview and Market Cluster Report

To download this report, please provide us with some information.

Leave this field blank

Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, St. Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Territory Indian Ocean British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Republic Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grena of Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Islands Northern Marianas Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Republic of the Congo Reunion Romania Russia Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the Sandwich Islands South South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu United States Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe

E-mail address is required

I would like to receive the latest updates from Newmark

By submitting your data via this form, you confirm that you are over 18 years old, that you have read and understood the privacy policy and that you agree to the collection, use and processing of your personal information by Newmark & ​​​​Company Real Estate. , Inc. in accordance with said policy.*

Thank you for sharing your information with Newmark!

Download 2021 Year-End Life Sciences Overview and Market Cluster Report

For more information, contact:

James D. Kuhn

President and Head of Investor Services

Jonathan Mazur

Senior Director General, National Research

Daniel Litman

Associate Director, Capital Markets Research

Additional Thought Leadership

Warning

Newmark Group Inc. published this content on February 08, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on February 08, 2022 19:11:04 UTC.

Public now 2022

All news from NEWMARK GROUP, INC.

Analyst Recommendations on NEWMARK GROUP, INC.

Sales 2021 2,798 million

Net income 2021 751 million

Net debt 2021

PER 2021 ratio 5.45x
2021 performance 0.25%
Capitalization 3,163 million
3,163 million
capi. / Sales 2021 1.13x
capi. / Sales 2022 1.05x
# of employees 4,150
Floating

Chart NEWMARK GROUP, INC.


Duration :

Period :




Newmark Group, Inc. Technical Analysis Chart |  MarketScreener

Trends Technical Analysis NEWMARK GROUP, INC.

Short term Middle term Long term
Tendencies Bearish Neutral Bullish



Evolution of the income statement

To sell

To buy

Medium consensus SURPASS
Number of analysts 4
Last closing price

$16.12

Average target price

$19.75

Average Spread / Target 22.5%


About Lillian Coomer

Check Also

Smithfield, VA man arrested for soliciting underage victims at Front Royal – Royal Examiner

On Thursday April 28, 2022, Front Royal Police Detectives opened an investigation into the solicitation …